focus -WSS

focus

author：leisure time 2025-10-02 20:49:37 - browse：259

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： FDA poised to publish guidelines for clinical trial diversity

explore

WSS

FDA panel to weigh safety of artificial wombs for preterm births

Liver decline slowed by off

Eli Lilly CEO gives to Mike Pence presidential super PAC

Information blocking fines are now fair game in health care

UnitedHealth argues against case alleging wrongful AI care denials

Covid’s new normal has set in amid another rise in cases

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Study finds gene variants tied to breast cancer risk in Black women

Continuity nursing helped my family in our darkest PICU moments

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Trump demands the U.S. pay no more for drugs than other countries … again

Reports of telehealth's death have been greatly exaggerated

Sports medicine is finally prioritizing gender equality

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Apple is now the first public company to be valued at $3 trillion

Making the case for fair compensation in clinical trials

entertainment

For longer

Liver decline slowed by off

Bird flu surveillance in wastewater gets boost from consortium

As a primary care physician, here's how I hope to partner with AI

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Why the drug industry's warnings on the IRA's impact fall short

explore

explore

focus

knowledge